The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1074
March 20, 2000
View Complete Issue         Table of Contents 2019 
A Pneumococcal Conjugate Vaccine for Infants and Children
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
A Pneumococcal Conjugate Vaccine for Infants and Children
March 20, 2000 (Issue: 1074)
The FDA has approved a conjugate heptavalent pneumococcal vaccine for prevention of invasive pneumococcal disease in infants and children.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: A Pneumococcal Conjugate Vaccine for Infants and Children
Article code: 1074a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.